Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

ferring pharmaceuticals pty ltd - human menopausal gonadotrophin, quantity: 1200 iu - injection, solvent for - excipient ingredients: water for injections; metacresol - menopur is indicated for the treatment of infertility in the following clinical situations:,anovulatory infertility, including polycystic ovarian disease (pcod), in women who have been unresponsive to treatment with clomiphene citrate.,controlled ovarian hyperstimulation to induce the development of multiple follicles for assisted reproductive technologies (art) (e.g. in vitro fertilisation/embryo transfer (ivf/et), gamete intra-fallopian transfer (gift) and intracytoplasmic sperm injection (icsi)).

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

ferring pharmaceuticals pty ltd - human menopausal gonadotrophin, quantity: 600 iu - injection, solvent for - excipient ingredients: water for injections; metacresol - menopur is indicated for the treatment of infertility in the following clinical situations:,anovulatory infertility, including polycystic ovarian disease (pcod), in women who have been unresponsive to treatment with clomiphene citrate.,controlled ovarian hyperstimulation to induce the development of multiple follicles for assisted reproductive technologies (art) (e.g. in vitro fertilisation/embryo transfer (ivf/et), gamete intra-fallopian transfer (gift) and intracytoplasmic sperm injection (icsi)).

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

ferring pharmaceuticals pty ltd - human menopausal gonadotrophin, quantity: 1200 iu - injection, solution - excipient ingredients: arginine hydrochloride; methionine; polysorbate 20; phenol; sodium hydroxide; dilute hydrochloric acid; water for injections - menopur is indicated for the treatment of infertility in the following clinical situations:,anovulatory infertility, including polycystic ovarian disease (pcod), in women who have been unresponsive to treatment with clomiphene citrate.,controlled ovarian hyperstimulation to induce the development of multiple follicles for assisted reproductive technologies (art) (e.g. in vitro fertilisation/embryo transfer (ivf/et), gamete intra-fallopian transfer (gift) and intracytoplasmic sperm injection (icsi)).

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

ferring pharmaceuticals pty ltd - human menopausal gonadotrophin, quantity: 600 iu - injection, solution - excipient ingredients: arginine hydrochloride; methionine; polysorbate 20; phenol; sodium hydroxide; dilute hydrochloric acid; water for injections - menopur is indicated for the treatment of infertility in the following clinical situations:,anovulatory infertility, including polycystic ovarian disease (pcod), in women who have been unresponsive to treatment with clomiphene citrate.,controlled ovarian hyperstimulation to induce the development of multiple follicles for assisted reproductive technologies (art) (e.g. in vitro fertilisation/embryo transfer (ivf/et), gamete intra-fallopian transfer (gift) and intracytoplasmic sperm injection (icsi)).

Kenja - Ingliż - Pharmacy and Poisons Board

human bioplazma llc h-2100 godollo transics milhaly ut 80hungary - human albumin - solution for infusion - 20%human albumin - blood substitutes and plasma protein fractions

Malta - Ingliż - Medicines Authority

biotest pharma gmbh landsteinerstrasse 5, 63303 dreieich, germany - human plasma, protein - solution for infusion - human plasma protein 200 g/l - blood substitutes and perfusion solutions

Stati Uniti - Ingliż - NLM (National Library of Medicine)

grifols usa, llc - albumin human (unii: zif514rvzr) (albumin human - unii:zif514rvzr) - albumin human 12.5 g in 50 ml - for restoration and maintenance of circulating blood volume where hypovolemia is demonstrated and colloid use is appropriate. when hypovolemia is long standing and hypoalbuminemia exists accompanied by adequate hydration or edema, 20-25% albumin solutions should be used.1,2,3 acute liver failure is a special situation in which both hypovolemia and hypoalbuminemia can be present. human albumin grifols® 25% can be used in such cases.1 human albumin grifols 25% may be of value in the treatment of shock or hypotension in renal dialysis patients.1 preoperative dilution of blood using albumin and crystalloid can be used in cardiopulmonary bypass procedures. albumin also may be used in the priming fluid.4,5,6 human albumin grifols 25% may be used to treat peripheral edema in patients with acute nephrosis who are refractory to cyclophosphamide, corticosteroid therapy or diuretics.1,2,7 human albumin grifols 25% may be indicated for subjects with hypoalbuminemia who are critically ill and/or actively bleeding. when

Stati Uniti - Ingliż - NLM (National Library of Medicine)

ethicon, inc - human thrombin (unii: 6k15abl77g) (human thrombin - unii:6k15abl77g) - human thrombin 2000 [iu] in 2 ml - evithrom® thrombin, topical (human), is indicated as an aid to hemostasis whenever oozing blood and minor bleeding from capillaries and small venules is accessible and control of bleeding by standard surgical techniques (such as suture, ligature or cautery) is ineffective or impractical. evithrom® thrombin, topical (human), may be used in conjunction with an absorbable gelatin sponge, usp. - do not use in individuals known to have an anaphylactic or severe systemic reaction to evithrom® or to human blood products. - do not use for the treatment of severe or brisk arterial bleeding. risk summary there are no data with evithrom® use in pregnant women to inform a drug-associated risk. animal reproduction studies have not been conducted with evithrom® . it is not known whether evithrom® can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. evithrom® should be given to a pregnant woman only if clearly needed. in the u.s. general population, the estimated background

Stati Uniti - Ingliż - NLM (National Library of Medicine)

deseret biologicals, inc. - human parvovirus b19 (unii: 94n635564t) (human parvovirus b19 - unii:94n635564t) - human parvovirus b19 15 in 1 ml - for the temporary relief of symptoms related to parvovirus including rash, swollen, painful joints and fever.** **these statements are based upon traditional homeopathic principles. they have not been reviewed by the food and drug administration. for the temporary relief of symptoms related to parvovirus including rash, swollen, painful joints and fever.** **these statements are based upon traditional homeopathic principles. they have not been reviewed by the food and drug administration.

Stati Uniti - Ingliż - NLM (National Library of Medicine)

deseret biologicals, inc - human parvovirus b19 (unii: 94n635564t) (human parvovirus b19 - unii:94n635564t) - human parvovirus b19 15 [hp_x] in 1 ml - for the temporary relief of symptoms related to parvovirus including rash, swollen, painful joints and fever.** **these statements are based upon traditional homeopathic practice. they have not been reviewed by the food and drug administration. for the temporary relief of symptoms related to parvovirus including rash, swollen, painful joints and fever.** **these statements are based upon traditional homeopathic practice. they have not been reviewed by the food and drug administration.